That Pay Gap Between Academic Men and Women Neurologists? It's Not Going Away

mark moranO ne year of suppressive therapy with valacyclovir at 1,000 mg per day appears to significantly reduce the dosage of pain medicine required for patients who experience herpes zoster ophthalmicus (HZO), a by the same authors, found that one year of suppressive therapy with valacyclovir reduced the number of episodes of new or worsening keratitis or iritis at both 12 and 18 months, reaching statistical significance at 18 months.Patients typically receive one week of valacyclovir in the acute phase of the disease.